Multimorbidity Patterns in Primary Care: Interactions among Chronic Diseases Using Factor Analysis

Objectives The primary objective of this study was to identify the existence of chronic disease multimorbidity patterns in the primary care population, describing their clinical components and analysing how these patterns change and evolve over time both in women and men. The secondary objective of this study was to generate evidence regarding the pathophysiological processes underlying multimorbidity and to understand the interactions and synergies among the various diseases. Methods This observational, retrospective, multicentre study utilised information from the electronic medical records of 19 primary care centres from 2008. To identify multimorbidity patterns, an exploratory factor analysis was carried out based on the tetra-choric correlations between the diagnostic information of 275,682 patients who were over 14 years of age. The analysis was stratified by age group and sex. Results Multimorbidity was found in all age groups, and its prevalence ranged from 13% in the 15 to 44 year age group to 67% in those 65 years of age or older. Goodness-of-fit indicators revealed sample values between 0.50 and 0.71. We identified five patterns of multimorbidity: cardio-metabolic, psychiatric-substance abuse, mechanical-obesity-thyroidal, psychogeriatric and depressive. Some of these patterns were found to evolve with age, and there were differences between men and women. Conclusions Non-random associations between chronic diseases result in clinically consistent multimorbidity patterns affecting a significant proportion of the population. Underlying pathophysiological phenomena were observed upon which action can be taken both from a clinical, individual-level perspective and from a public health or population-level perspective.

[1]  F. Tinahones,et al.  The obese healthy paradox: is inflammation the answer? , 2010, The Biochemical journal.

[2]  S. Göransson,et al.  Frequent use of the hospital emergency department is indicative of high use of other health care services. , 2001, Annals of emergency medicine.

[3]  Martin Fortin,et al.  Prevalence of Multimorbidity Among Adults Seen in Family Practice , 2005, The Annals of Family Medicine.

[4]  J G Barbee,et al.  Mixed Symptoms and Syndromes of Anxiety and Depression: Diagnostic, Prognostic, and Etiologic Issues , 1998, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[5]  J. Valderas,et al.  Epidemiology and impact of multimorbidity in primary care: a retrospective cohort study. , 2011, The British journal of general practice : the journal of the Royal College of General Practitioners.

[6]  Thomas Pederson,et al.  Multimorbidity Clusters: Clustering Binary Data From Multimorbidity Clusters: Clustering Binary Data From a Large Administrative Medical Database , 2009, AMR 2009.

[7]  B. Tabachnick,et al.  Using Multivariate Statistics , 1983 .

[8]  M. Mcdermott.  In the clinic. Hypothyroidism. , 2009 .

[9]  John T. Wei,et al.  Obesity and benign prostatic hyperplasia: clinical connections, emerging etiological paradigms and future directions. , 2009, The Journal of urology.

[10]  Duane T. Wegener,et al.  Evaluating the use of exploratory factor analysis in psychological research. , 1999 .

[11]  B. Starfield.  Threads and Yarns: Weaving the Tapestry of Comorbidity , 2006, The Annals of Family Medicine.

[12]  J. Concato,et al.  Vector Model of Complexity , 2008, Journal of general internal medicine.

[13]  L. Fratiglioni,et al.  Aging with multimorbidity: A systematic review of the literature , 2011, Ageing Research Reviews.

[14]  J. Sweeney,et al.  Drug abuse in schizophrenic patients: clinical correlates and reasons for use. , 1991, The American journal of psychiatry.

[15]  H. Britt,et al.  Prevalence and patterns of multimorbidity in Australia , 2008, The Medical journal of Australia.

[16]  Christopher B Forrest,et al.  Comorbidity: Implications for the Importance of Primary Care in ‘Case’ Management , 2003, The Annals of Family Medicine.

[17]  Henks Lamberts,et al.  ICPC : international classification of primary care , 1987 .

[18]  Hendrik van den Bussche,et al.  Multimorbidity Patterns in the Elderly: A New Approach of Disease Clustering Identifies Complex Interrelations between Chronic Conditions , 2010, PloS one.

[19]  D. Battistutta,et al.  Multivariate methods to identify cancer-related symptom clusters. , 2009, Research in nursing & health.

[20]  J. Pandolfino,et al.  Obesity: a challenge to esophagogastric junction integrity. , 2006, Gastroenterology.

[21]  B. Starfield,et al.  Defining Comorbidity: Implications for Understanding Health and Health Services , 2009, The Annals of Family Medicine.

[22]  V. Rodríguez,et al.  Guía de buena práctica clínica en depresión y ansiedad , 2003 .

[23]  Anne Corbett,et al.  Alzheimer's disease , 2011, The Lancet.

[24]  John F. Steiner,et al.  Descriptions of Barriers to Self-Care by Persons with Comorbid Chronic Diseases , 2003, The Annals of Family Medicine.

[25]  A. Vidal-Puig,et al.  Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome--an allostatic perspective. , 2010, Biochimica et biophysica acta.

[26]  M. Fortin,et al.  Randomized Controlled Trials: Do They Have External Validity for Patients With Multiple Comorbidities? , 2006, The Annals of Family Medicine.

[27]  A. Avenell,et al.  Systematic Review of Long-term Lifestyle Interventions to Prevent Weight Gain and Morbidity in Adults. Authors: , 2009 .

[28]  T. Sørensen,et al.  Obesity as a clinical and public health problem: is there a need for a new definition based on lipotoxicity effects? , 2010, Biochimica et biophysica acta.

[29]  M. McDonagh,et al.  The American College of Rheumatology 1990 criteria for the classification of fibromyalgia , 2011 .

[30]  Christine Laine,et al.  In the Clinic , 2007, Annals of Internal Medicine.

[31]  D. Comas,et al.  [Primary and secondary prevention of stroke: a guideline]. , 2009, Medicina clinica.

[32]  Martin Fortin,et al.  Multimorbidity is common to family practice: is it commonly researched? , 2005, Canadian family physician Medecin de famille canadien.

[33]  Martin Fortin,et al.  Relationship Between Multimorbidity and Health-Related Quality of Life of Patients in Primary Care , 2006, Quality of Life Research.

[34]  J A Knottnerus,et al.  Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. , 1998, Journal of clinical epidemiology.

[35]  S. Corrao,et al.  Co-morbidity does not reflect complexity in internal medicine patients. , 2007, European journal of internal medicine.

[36]  S. Schatzki.  The clinic. , 1994, AJR. American journal of roentgenology.

[37]  E. Fernández,et al.  Prevalence of cigarette smoking by birth cohort among males and females in Spain, 1910–1990 , 2003, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[38]  R. Drake,et al.  Dual diagnosis: a review of etiological theories. , 1998, Addictive behaviors.

[39]  M. Stanley,et al.  Effect of neuroleptics and of potential new antipsychotic agents (MJ 13859-1 and MJ 13980-1) on a monkey model of tardive dyskinesia , 2005, Journal of Neural Transmission.

[40]  P. Tugwell,et al.  The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. , 1990, Arthritis and rheumatism.

[41]  J. Gérvas,et al.  La comorbilidad en atención primaria , 2006 .

[42]  M. Höfler,et al.  Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study , 2011, BMJ : British Medical Journal.

[43]  B. Starfield,et al.  Comorbidity and the Use of Primary Care and Specialist Care in the Elderly , 2005, The Annals of Family Medicine.

[44]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[45]  J. Guralnik,et al.  Assessing the impact of comorbidity in the older population. , 1996, Annals of epidemiology.

[46]  H. Minuk,et al.  Metabolic syndrome. , 2005, Journal of insurance medicine.

[47]  R. Coccurello,et al.  Potential mechanisms of atypical antipsychotic-induced metabolic derangement: clues for understanding obesity and novel drug design. , 2010, Pharmacology & therapeutics.

[48]  W. Compton,et al.  Substance abuse in the United States: Findings from recent epidemiologic studies , 2009, Current psychiatry reports.

[49]  F. Berenbaum,et al.  Obesity and osteoarthritis: more complex than predicted! , 2006, Annals of the rheumatic diseases.

[50]  A L Dannenberg,et al.  The epidemiology of varicose veins: the Framingham Study. , 1988, American journal of preventive medicine.

[51]  J A Knottnerus,et al.  Problems in determining occurrence rates of multimorbidity. , 2001, Journal of clinical epidemiology.

[52]  Hyon K. Choi,et al.  Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile. , 2008, Rheumatology.

[53]  A. Pries,et al.  Ischaemic heart disease in women: are there sex differences in pathophysiology and risk factors? Position paper from the working group on coronary pathophysiology and microcirculation of the European Society of Cardiology. , 2011, Cardiovascular research.

[54]  B. Starfield.  Challenges to primary care from co- and multi-morbidity , 2011, Primary Health Care Research & Development.

[55]  Jeroan J. Allison,et al.  Patient Complexity: More Than Comorbidity. The Vector Model of Complexity , 2007, Journal of General Internal Medicine.

[56]  W. Satariano,et al.  Causes and consequences of comorbidity: a review. , 2001, Journal of clinical epidemiology.

[57]  Jason W. Osborne,et al.  Best practices in exploratory factor analysis: four recommendations for getting the most from your analysis. , 2005 .

[58]  M. Hilton,et al.  Patterns of multimorbidity in working Australians , 2011, Population health metrics.

[59]  D H Barlow,et al.  Mixed anxiety-depression and its implications for models of mood and anxiety disorders. , 2000, Comprehensive psychiatry.

[60]  J. Mckenney,et al.  Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force. , 2006, The American journal of cardiology.

[61]  K. Choi,et al.  The Prevalence of Metabolic Syndrome in Patients with Gout: A Multicenter Study , 2005, Journal of Korean medical science.

[62]  C. Brayne,et al.  Variation Over Time in the Association between Polypharmacy and Mortality in the Older Population , 2011, Drugs & aging.

[63]  Klaus D. Kubinger,et al.  On artifi cial results due to using factor analysis for dichotomous variables , 2003 .